Results 261 to 270 of about 183,292 (313)

Recurrent petechial hemorrhages and hemorrhagic vesicles of the oral mucosa

The Journal of the American Dental Association, 1985
The foregoing case is an example of amyloidosis in which biopsy of a hemorrhagic vesicle on the buccal mucosa established the diagnosis. Once the diagnosis was made, the patient's cardiomyopathy, nephrotic syndrome, hepatomegaly, GI hemorrhage, hematuria, and oral lesions readily were explained.
J L, Jensen, R W, Correll, G W, DeBoom
openaire   +2 more sources

Oral Anticoagulants and Intracranial Hemorrhage

Stroke, 1995
Background Intracranial hemorrhage is the most feared and lethal complication of oral anticoagulation. We review the frequency, predictors, and prognosis of this most common neurological complication of oral anticoagulation.
R G, Hart, B S, Boop, D C, Anderson
openaire   +2 more sources

Hemorrhagic complications of oral anticoagulant therapy

Clinics in Geriatric Medicine, 2001
Hemorrhage is the major complication of anticoagulant therapy. The criteria for classifying the severity of bleeding has varied between studies, which has resulted in variability in the rate of bleeding reported in the literature. The major determinants of oral anticoagulant-related bleeding are the intensity of the anticoagulant effect, baseline ...
openaire   +2 more sources

Management of oral anticoagulation after intracerebral hemorrhage

International Journal of Stroke, 2019
Background The most recent years have significantly expanded knowledge regarding risks and benefits of resuming oral anticoagulation (OAC) after intracerebral hemorrhage (ICH). No randomized data is yet available, though several large observational studies and meta-analyses have investigated the impact of resuming OAC on thromboembolic versus ...
Joji B Kuramatsu, Hagen B Huttner
openaire   +2 more sources

Isolated Retinal Hemorrhages Associated with Oral Contraceptives

American Journal of Ophthalmology, 1977
Seven patients had isolated retinal hemorrhages without other systemic or ocular disease in a six-year period. Six patients were females, of whom five were taking oral contraceptives. The number of patients taking contraceptives and the fact that one patient had a similar episode earlier during pregnancy suggested a hormonal etiology.
E D, Svarc, D, Werner
openaire   +2 more sources

Spinal subarachnoid hemorrhage complicating oral anticoagulant therapy

European Journal of Radiology, 2001
Spinal subarachnoid hemorrhage (SAH) is rare clinical entity possible owing to the diluting and fibrinolytic effects of cerebrospinal fluid (CSF). When it occurs, it is most commonly encountered in the thoracic segment of the subarachnoid space. We present a case of a 50-year-old man who sustained spinal SAH in the cervical and thoracic segments ...
M, Cihangiroglu, S, Bulut, S, Nayak
openaire   +2 more sources

Thrombocythemia as a cause of oral hemorrhage

Oral Surgery, Oral Medicine, Oral Pathology, 1977
Thrombocythemia is characterized by an increase in platelet numbers coupled with abnormal function. Three cases diagnosed after referral to an oral surgeon are presented. In each case the reason for referral concerned excessive dental hemorrhage. Thrombocythemia should be included in the differential diagnosis in cases of oral hemorrhage.
openaire   +2 more sources

[Hemorrhagic diathesis and oral surgery].

Minerva stomatologica, 1991
Dental and/or periodontal diseases are an important clinical and social problem in patients with hemorrhagic diathesis. The possibility to overcome it successfully depends on the type of hemorrhagic disease and on the organization of hematological and odontostomatological centres: in fact, the best results in the surgery of these patients are obtained ...
G, Grignani, C, De Rysky
openaire   +1 more source

Postoperative hemorrhage in oral surgery

Oral Surgery, Oral Medicine, Oral Pathology, 1956
J L, BRADLEY, S, JAKUBS
openaire   +2 more sources

[Hemorrhagic stroke and new oral anticoagulants].

Annales francaises d'anesthesie et de reanimation, 2015
The recent release of new oral anticoagulants (NOAC) raises the question of the management of intracranial hemorrhage occurring during treatment with these molecules. Dabigatran, rivaroxaban and apixaban have different pharmacological characteristics that physicians need to know to adjust their prescription to each patient.
V, Derlon, G, Corbonnois, M, Martin, M, Toussaint-Hacquard, G, Audibert   +4 more
openaire   +1 more source